Literature DB >> 29204920

Reply to the letter "Laryngopharyngeal reflux disease in the elderly".

Jérôme R Lechien1,2,3,4, Bernard Harmegnies5, Sven Saussez6,7,8.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29204920     DOI： 10.1007/s00405-017-4826-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  5 in total

1.  Impact of age on laryngopharyngeal reflux disease presentation: a multi-center prospective study.

Authors:  Jérôme R Lechien; Camille Finck; Kathy Huet; Mohamad Khalife; Anne-Françoise Fourneau; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-17       Impact factor: 2.503

Review 2.  Lacunar infarct.

Authors:  Marcello Lastilla
Journal:  Clin Exp Hypertens       Date:  2006 Apr-May       Impact factor: 1.749

3.  The Reliability of the Reflux Finding Score Among General Otolaryngologists.

Authors:  Brent A Chang; S Danielle MacNeil; Murray D Morrison; Patricia K Lee
Journal:  J Voice       Date:  2015-06-26       Impact factor: 2.009

4.  LPR: how different diagnostic tools shape the outcomes of treatment.

Authors:  Yichen Wan; Yan Yan; Furong Ma; Li Wang; Peiquan Lu; Allison Maytag; Jack J Jiang
Journal:  J Voice       Date:  2014-02-01       Impact factor: 2.009

5.  Impact of laryngopharyngeal reflux on subjective and objective voice assessments: a prospective study.

Authors:  Jérôme R Lechien; Kathy Huet; Mohamad Khalife; Anne-Françoise Fourneau; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  J Otolaryngol Head Neck Surg       Date:  2016-11-08
  5 in total
  1 in total

1.  Gender differences in the presentation of dysphonia related to laryngopharyngeal reflux disease: a case-control study.

Authors:  Jérôme R Lechien; Kathy Huet; Mohamad Khalife; Anne-Françoise Fourneau; Camille Finck; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-26       Impact factor: 2.503
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.